Latest period
$251.00M
YoY change
-216.9%
5Y CAGR
—
Peak year (2021)
$2.04B
Latest annual
−$636.00M
Free Cash Flow history chart for Molina Healthcare (MOH) from 2002 to 2025
Latest: −$636.00M
Free Cash Flow growth chart for Molina Healthcare (MOH) from 2002 to 2025
Latest: -216.9%
Free Cash Flow history table for Molina Healthcare (MOH) from 2002 to 2025
| 2025 | −$636.00M | -216.9% | −$1.18B | ||
| 2024 | $544.00M | -65.5% | −$1.03B | ||
| 2023 | $1.58B | +131.4% | +$896.00M | ||
| 2022 | $682.00M | -66.6% | −$1.36B | ||
| 2021 | $2.04B | +12.4% | +$226.00M | ||
| 2020 | $1.82B | +390.8% | +$1.45B | ||
| 2019 | $370.00M | -207.6% | +$714.00M | ||
| 2018 | −$344.00M | -147.9% | −$1.06B | ||
| 2017 | $718.00M | +44.5% | +$221.00M | ||
| 2016 | $497.00M | -49.9% | −$496.00M | ||
| 2015 | $993.00M | +5.0% | +$47.68M | ||
| 2014 | $945.32M | +927.1% | +$853.29M | ||
| 2013 | $92.03M | -65.4% | −$174.12M | ||
| 2012 | $266.15M | +61.5% | +$101.34M | ||
| 2011 | $164.81M | +45.7% | +$51.71M | ||
| 2010 | $113.11M | -5.0% | −$6.00M | ||
| 2009 | $119.11M | +1974.7% | +$113.37M | ||
| 2008 | $5.74M | -95.8% | −$130.59M | ||
| 2007 | $136.33M | +66.2% | +$54.31M | ||
| 2006 | $82.02M | -1.5% | −$1.28M | ||
| 2005 | $83.30M | +3.8% | +$3.01M | ||
| 2004 | $80.28M | +115.8% | +$43.09M | ||
| 2003 | $37.20M | -5.9% | −$2.32M | ||
| 2002 | $39.52M | — | — |
- 2025−$636.00M-216.9%
- 2024$544.00M-65.5%
- 2023$1.58B+131.4%
- 2022$682.00M-66.6%
- 2021$2.04B+12.4%
- 2020$1.82B+390.8%
- 2019$370.00M-207.6%
- 2018−$344.00M-147.9%
- 2017$718.00M+44.5%
- 2016$497.00M-49.9%
- 2015$993.00M+5.0%
- 2014$945.32M+927.1%
- 2013$92.03M-65.4%
- 2012$266.15M+61.5%
- 2011$164.81M+45.7%
- 2010$113.11M-5.0%
- 2009$119.11M+1974.7%
- 2008$5.74M-95.8%
- 2007$136.33M+66.2%
- 2006$82.02M-1.5%
- 2005$83.30M+3.8%
- 2004$80.28M+115.8%
- 2003$37.20M-5.9%
- 2002$39.52M—
Free Cash Flow values are taken from Molina Healthcare's reported cash flow statements (quarterly 10-Q and annual 10-K filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the filing date. YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
About Free Cash Flow at Molina Healthcare (MOH)
Free Cash Flow for Molina Healthcare (MOH): headline value $251.00M · YoY -216.9%. Annual and quarterly series, chart, and tables are below.
Headline figure above is from the reporting period ending (reported ). Chart and table below cover the full reported history back to .
2025's annual free cash flow for Molina Healthcare (MOH) came in at −$636.00M – plunged 216.9% year-over-year.
Between 2021 and 2025, Molina Healthcare free cash flow plunged 131.1%, falling from $2.04B to −$636.00M.
Across the available history, free cash flow reached its high of $2.04B in 2021 and its low of −$636.00M in 2025.
Molina Healthcare Free Cash Flow by Year
Molina Healthcare Free Cash Flow 2025: −$636.00M
2025's free cash flow for Molina Healthcare came in at −$636.00M, plunged 216.9% below 2024. This figure represents the lowest annual value in the available history.
Molina Healthcare Free Cash Flow 2024: $544.00M
Molina Healthcare posted free cash flow of $544.00M in 2024, plunged 65.5% below 2023.
Molina Healthcare Free Cash Flow 2023: $1.58B
In 2023, Molina Healthcare reported free cash flow of $1.58B, surged 131.4% from 2022.
Molina Healthcare Free Cash Flow 2022: $682.00M
Molina Healthcare free cash flow in 2022 was $682.00M, plunged 66.6% below 2021.
Molina Healthcare Free Cash Flow 2021: $2.04B
Molina Healthcare free cash flow in 2021 was $2.04B.
See more financial history for Molina Healthcare (MOH).
Sector peers by Free Cash Flow
Healthcare peers of Molina Healthcare (MOH), ranked by their latest free cash flow
| $19.70B | |
| $17.82B | |
| $16.07B | |
| $12.36B | |
| $8.97B | |
| $8.67B | |
| $8.10B | |
| $4.52B |
- $19.70B
- $17.82B
- $16.07B
- $12.36B
- $8.97B
- $8.67B
- $8.10B
- $4.52B
Frequently asked questions
Molina Healthcare (MOH) Key Financials
Charts, filings, and peer comparison for every metric
Explore more
Deep-dives across the income statement, cash flow, capital return, and valuation